Hepatocyte growth factor
| GO Term | Evidence Code | Reference |
|---|---|---|
| cell morphogenesis | ||
| liver development | ||
| liver development | ||
| proteolysis | ||
| positive regulation of cell migration |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| obsolete extracellular space |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| signaling receptor binding | ||
| growth factor activity | ||
| chemoattractant activity | ||
| chemoattractant activity | ||
| identical protein binding |
| Pathway Name | Organism |
|---|---|
| Drug-mediated inhibition of MET activation | Mus musculus |
| MET Receptor Activation | Mus musculus |
| MET activates PI3K/AKT signaling | Mus musculus |
| MET activates PTK2 signaling | Mus musculus |
| MET activates PTPN11 | Mus musculus |
| MET activates RAP1 and RAC1 | Mus musculus |
| MET activates RAS signaling | Mus musculus |
| MET activates STAT3 | Mus musculus |
| MET interacts with TNS proteins | Mus musculus |
| MET receptor recycling | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0110497 | autosomal recessive nonsyndromic deafness 39 | |
| DOID:1612 | breast cancer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026